The Clalit Analysis Institute, in collaboration with researchers from Harvard College, analyzed one of many world’s largest built-in well being document databases to look at the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine towards the Delta variant of SARS-CoV-2. The examine gives the most important peer-reviewed analysis of the effectiveness of a 3rd “booster” dose of a COVID-19 vaccine in a nationwide mass-vaccination setting. The examine was performed in Israel. It’s revealed in The Lancet journal.
Many international locations are at the moment experiencing a resurgence of SARS-CoV-2 infections regardless of hitherto